Literature DB >> 25271085

Expanding the mutation spectrum in 182 Spanish probands with craniosynostosis: identification and characterization of novel TCF12 variants.

Beatriz Paumard-Hernández1, Julia Berges-Soria1, Eva Barroso2, Carlos I Rivera-Pedroza1, Virginia Pérez-Carrizosa1, Sara Benito-Sanz2, Eva López-Messa1, Fernando Santos2, Ignacio I García-Recuero3, Ana Romance3, Juliana María Ballesta-Martínez4, Vanesa López-González4, Ángel Campos-Barros2, Jaime Cruz5, Encarna Guillén-Navarro6, Jaime Sánchez Del Pozo5, Pablo Lapunzina2, Sixto García-Miñaur2, Karen E Heath2.   

Abstract

Craniosynostosis, caused by the premature fusion of one or more of the cranial sutures, can be classified into non-syndromic or syndromic and by which sutures are affected. Clinical assignment is a difficult challenge due to the high phenotypic variability observed between syndromes. During routine diagnostics, we screened 182 Spanish craniosynostosis probands, implementing a four-tiered cascade screening of FGFR2, FGFR3, FGFR1, TWIST1 and EFNB1. A total of 43 variants, eight novel, were identified in 113 (62%) patients: 104 (92%) detected in level 1; eight (7%) in level 2 and one (1%) in level 3. We subsequently screened additional genes in the probands with no detected mutation: one duplication of the IHH regulatory region was identified in a patient with craniosynostosis Philadelphia type and five variants, four novel, were identified in the recently described TCF12, in probands with coronal or multisuture affectation. In the 19 Saethre-Chotzen syndrome (SCS) individuals in whom a variant was detected, 15 (79%) carried a TWIST1 variant, whereas four (21%) had a TCF12 variant. Thus, we propose that TCF12 screening should be included for TWIST1 negative SCS patients and in patients where the coronal suture is affected. In summary, a molecular diagnosis was obtained in a total of 119/182 patients (65%), allowing the correct craniosynostosis syndrome classification, aiding genetic counselling and in some cases provided a better planning on how and when surgical intervention should take place and, subsequently the appropriate clinical follow up.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25271085      PMCID: PMC4463497          DOI: 10.1038/ejhg.2014.205

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  29 in total

Review 1.  Diverse roles of eph receptors and ephrins in the regulation of cell migration and tissue assembly.

Authors:  Alexei Poliakov; Marisa Cotrina; David G Wilkinson
Journal:  Dev Cell       Date:  2004-10       Impact factor: 12.270

2.  A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome.

Authors:  M Muenke; K W Gripp; D M McDonald-McGinn; K Gaudenz; L A Whitaker; S P Bartlett; R I Markowitz; N H Robin; N Nwokoro; J J Mulvihill; H W Losken; J B Mulliken; A E Guttmacher; R S Wilroy; L A Clarke; G Hollway; L C Adès; E A Haan; J C Mulley; M M Cohen; G A Bellus; C A Francomano; D M Moloney; S A Wall; A O Wilkie
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

3.  The origin of EFNB1 mutations in craniofrontonasal syndrome: frequent somatic mosaicism and explanation of the paucity of carrier males.

Authors:  Stephen R F Twigg; Kazuya Matsumoto; Alexa M J Kidd; Anne Goriely; Indira B Taylor; Richard B Fisher; A Jeannette M Hoogeboom; Irene M J Mathijssen; M Teresa Lourenco; Jenny E V Morton; Elizabeth Sweeney; Louise C Wilson; Han G Brunner; John B Mulliken; Steven A Wall; Andrew O M Wilkie
Journal:  Am J Hum Genet       Date:  2006-04-28       Impact factor: 11.025

4.  Saethre-Chotzen syndrome caused by TWIST 1 gene mutations: functional differentiation from Muenke coronal synostosis syndrome.

Authors:  Wolfram Kress; Christian Schropp; Gabriele Lieb; Birgit Petersen; Maria Büsse-Ratzka; Jürgen Kunz; Edeltraut Reinhart; Wolf-Dieter Schäfer; Johanna Sold; Florian Hoppe; Jan Pahnke; Andreas Trusen; Niels Sörensen; Jürgen Krauss; Hartmut Collmann
Journal:  Eur J Hum Genet       Date:  2006-01       Impact factor: 4.246

5.  Genotype-phenotype correlation for nucleotide substitutions in the IgII-IgIII linker of FGFR2.

Authors:  M Oldridge; P W Lunt; E H Zackai; D M McDonald-McGinn; M Muenke; D M Moloney; S R Twigg; J K Heath; T D Howard; G Hoganson; D M Gagnon; E W Jabs; A O Wilkie
Journal:  Hum Mol Genet       Date:  1997-01       Impact factor: 6.150

Review 6.  Growth of the normal skull vault and its alteration in craniosynostosis: insights from human genetics and experimental studies.

Authors:  Gillian M Morriss-Kay; Andrew O M Wilkie
Journal:  J Anat       Date:  2005-11       Impact factor: 2.610

7.  Clinical variability in patients with Apert's syndrome.

Authors:  E Lajeunie; R Cameron; V El Ghouzzi; N de Parseval; P Journeau; M Gonzales; A L Delezoide; J Bonaventure; M Le Merrer; D Renier
Journal:  J Neurosurg       Date:  1999-03       Impact factor: 5.115

8.  De novo alu-element insertions in FGFR2 identify a distinct pathological basis for Apert syndrome.

Authors:  M Oldridge; E H Zackai; D M McDonald-McGinn; S Iseki; G M Morriss-Kay; S R Twigg; D Johnson; S A Wall; W Jiang; C Theda; E W Jabs; A O Wilkie
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

9.  Maternal complex chromosomal rearrangement leads to TCF12 microdeletion in a patient presenting with coronal craniosynostosis and intellectual disability.

Authors:  Pauline Le Tanno; Brice Poreau; Francoise Devillard; Gaëlle Vieville; Florence Amblard; Pierre-Simon Jouk; Véronique Satre; Charles Coutton
Journal:  Am J Med Genet A       Date:  2014-03-19       Impact factor: 2.802

10.  Mutations of ephrin-B1 (EFNB1), a marker of tissue boundary formation, cause craniofrontonasal syndrome.

Authors:  Stephen R F Twigg; Rui Kan; Christian Babbs; Elena G Bochukova; Stephen P Robertson; Steven A Wall; Gillian M Morriss-Kay; Andrew O M Wilkie
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-27       Impact factor: 11.205

View more
  19 in total

Review 1.  Skull base development and craniosynostosis.

Authors:  Susan I Blaser; Nancy Padfield; David Chitayat; Christopher R Forrest
Journal:  Pediatr Radiol       Date:  2015-09-07

2.  The Right Gene, Expressed at the Wrong Time, or at the Wrong Place.

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2018-08-24

Review 3.  Clinical genetics of craniosynostosis.

Authors:  Andrew O M Wilkie; David Johnson; Steven A Wall
Journal:  Curr Opin Pediatr       Date:  2017-12       Impact factor: 2.856

4.  Molecular basis of the first reported clinical case of congenital combined deficiency of coagulation factors.

Authors:  Da-Yun Jin; Brian O Ingram; Darrel W Stafford; Jian-Ke Tie
Journal:  Blood       Date:  2017-07-05       Impact factor: 22.113

5.  TCF12 haploinsufficiency causes autosomal dominant Kallmann syndrome and reveals network-level interactions between causal loci.

Authors:  Erica E Davis; Ravikumar Balasubramanian; Zachary A Kupchinsky; David L Keefe; Lacey Plummer; Kamal Khan; Blazej Meczekalski; Karen E Heath; Vanesa Lopez-Gonzalez; Mary J Ballesta-Martinez; Gomathi Margabanthu; Susan Price; James Greening; Raja Brauner; Irene Valenzuela; Ivon Cusco; Paula Fernandez-Alvarez; Margaret E Wierman; Taibo Li; Kasper Lage; Priscila Sales Barroso; Yee-Ming Chan; William F Crowley; Nicholas Katsanis
Journal:  Hum Mol Genet       Date:  2020-08-11       Impact factor: 6.150

Review 6.  Genetic advances in craniosynostosis.

Authors:  Wanda Lattanzi; Marta Barba; Lorena Di Pietro; Simeon A Boyadjiev
Journal:  Am J Med Genet A       Date:  2017-02-04       Impact factor: 2.802

7.  Chromosome 1p31.1p31.3 Deletion in a Patient with Craniosynostosis, Central Nervous System and Renal Malformation: Case Report and Review of the Literature.

Authors:  Carlos I Rivera-Pedroza; Jimena Barraza-García; Beatriz Paumard-Hernández; Julian Nevado; Carlos Orbea-Gallardo; Jaime Sánchez Del Pozo; Karen E Heath
Journal:  Mol Syndromol       Date:  2016-11-17

Review 8.  Understanding craniosynostosis as a growth disorder.

Authors:  Kevin Flaherty; Nandini Singh; Joan T Richtsmeier
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2016-03-22       Impact factor: 5.814

9.  TCF12 is mutated in anaplastic oligodendroglioma.

Authors:  Karim Labreche; Iva Simeonova; Aurélie Kamoun; Vincent Gleize; Daniel Chubb; Eric Letouzé; Yasser Riazalhosseini; Sara E Dobbins; Nabila Elarouci; Francois Ducray; Aurélien de Reyniès; Diana Zelenika; Christopher P Wardell; Mathew Frampton; Olivier Saulnier; Tomi Pastinen; Sabrina Hallout; Dominique Figarella-Branger; Caroline Dehais; Ahmed Idbaih; Karima Mokhtari; Jean-Yves Delattre; Emmanuelle Huillard; G Mark Lathrop; Marc Sanson; Richard S Houlston
Journal:  Nat Commun       Date:  2015-06-12       Impact factor: 17.694

10.  γ-Glutamyl carboxylase mutations differentially affect the biological function of vitamin K-dependent proteins.

Authors:  Zhenyu Hao; Da-Yun Jin; Xuejie Chen; Leon J Schurgers; Darrel W Stafford; Jian-Ke Tie
Journal:  Blood       Date:  2021-01-28       Impact factor: 25.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.